Immune Control is Drug Discovery in United States that focus on organ transplant rejection business. Founded in 2001. They cover business area such as developer, serotonin-base immunotherapeutic, autoimmunity, traditional treatment, orally available, small molecule, serotonin receptor, immune cell, healthcare professional, autoimmune/inflammatory disease, hematologic cancer, organ transplant rejection.
2001
( 23 years old in 2024 )
Organ Transplant Rejection
-
200 Barr Harbor Drive
Four Tower Bridge, Suite 400
Conshohocken, PA 19428
United States
Private
developerserotonin-base immunotherapeuticautoimmunitytraditional treatmentorally available, small moleculeserotonin receptorimmune cellhealthcare professionalautoimmune/inflammatory diseasehematologic cancerorgan transplant rejection
* We use standard office opening hours in near Immune Control's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immune Control is Drug Discovery business from United States that founded in 2001 (23 years old in 2024), Immune Control business is focusing on Organ Transplant Rejection.
Immune Control headquarter office and corporate office address is located in 200 Barr Harbor Drive Four Tower Bridge, Suite 400 Conshohocken, PA 19428 United States.
Immune Control was founded in United States.
In 2024, Immune Control is currently focus on organ transplant rejection sector.
Above is snippet of Google Trends for "organ transplant rejection" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immune Control, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
